Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 14, 2021
ANGUS Chemical Company announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO™ tromethamine buffers. ANGUS is the world's largest and only fully integrated original manufacturer of TRIS AMINO buffers, which are ...
read more
ANI Pharmaceuticals has acquired ANDAs for 23 previously marketed generic drug products from IDT Australia, Ltd. for $2.6 million and a limited single-digit royalty for one product.
read more
ANI has received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
ANI announced the receipt of clinical data on Cortrophin® Gel from a study that evaluated the blood-level cortisol response in a 20-person healthy volunteer population.
read more
Monday, November 22, 2021
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, ...
read more
ANI has completed the acquisition of a portfolio of six generic products, related manufacturing and supply agreements from Amneal and Impax for cash consideration of $2.3 million.
read more
Tuesday, January 07, 2014
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling.") The ...
read more
Monday, November 04, 2019
ANI Pharmaceuticals announced the launch of its new CDMO brand, ANI Global Source. This action follows the integration of WellSpring Pharma Services, acquired one year ago.
read more
ANI Pharmaceuticals has signed definitive agreements to acquire a portfolio of generic products and other assets from Amneal and Impax for undisclosed cash consideration.
read more
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.
read more
Anixa Biosciences and OntoChem have completed the initial in silico screening process of their drug discovery program and have identified an additional specific compound, as well as multiple analogs, that could function as inhibitors of the main ...
read more
Thursday, January 18, 2018
Anokion has announced the appointment of John Hohneker, M.D., as president and chief executive officer, effective January 22.
read more
Antares Vision Group announced a strategic partnership with LedgerDomain which will strengthen the Verification Router Service (VRS) solution delivered by rfxcel, a business unit of Antares Vision Group, and sets the stage for interoperable messaging...
read more
Antares Vision has renewed its strategic partnership with Xyntek.
read more